Clinical trial Recruiting at 1 site Observational Ages 21 to 99

Understanding the human metagenome's role in metabolic diseases

Official title: Understanding the Role of the Human Metagenome in Obesity, Metabolic Diseases, Chronic Inflammation, Sarcopenia and Sarcopenic Obesity - a Pilot Study

Run by Sengkang General Hospital · NCT06363253 · Data updated 2026-11-12

This study is trying to see how the bacteria and substances in our bodies relate to health and conditions like obesity and muscle loss by looking at samples from different people.

More Obesity trials

Quick facts

Study typeObservational
Ages21 Years to 99 Years
SexAll
Enrollment600 (estimated)
SponsorSengkang General Hospital
Academic / other
Locations1 site (Singapore)
StatusRecruiting
StartedAugust 14, 2023
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedMay 15, 2025
Trial IDNCT06363253 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals who are obese, sarcopenic, or healthy controls without obesity or sarcopenia.

Probably not a fit

Patients with intestinal stomas or those unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study aims to explore the role of the human metagenome and associated metabolites in health and various metabolic diseases, particularly obesity and sarcopenia. Participants will provide fecal, salivary, urine, serum, and mucosal samples for metagenomic sequencing and metabolite analysis. The study seeks to identify differences in the metagenome and metabolome across different health states, with the potential for future personalized therapeutic applications. A cohort of healthy controls will also be included for comparison.

Why it matters

Potential benefit: If successful, this study could lead to personalized treatment strategies for patients with metabolic disorders.

How similar studies have gone: While the approach of studying the metagenome in relation to metabolic diseases is gaining interest, this specific study's focus on non-bacteriome species and their metabolites is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (obese cohort):

* Obese (BMI\>27.5kg/m2)

Inclusion Criteria (sarcopenic cohort):

* Sarcopenic patients, defined as 1) low handgrip strength (\<26 for males; \<18kg for females), AND/OR low gait speed (\<0.8m/s) AND low muscle mass (\<7.0kg/m2 for males; \<5.7kg/m2 for females)

Inclusion Criteria (control cohort):

\- Healthy subjects without sarcopenia, and not obese (BMI\<27.5kg/m2)

Exclusion Criteria:

* No informed consent
* Presence of intestinal stoma, hence inability to collect fecal samples

Where it's running

  • Sengkang General Hospital
    Singapore, Singapore
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.